This page lists the SEC filings reported by Kinnevik AB (publ).
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2023-05-22 | Kinnevik AB (publ) | RECURSION PHARMACEUTICALS, INC. | 10,405,668 | 5.6% | EDGAR |
| SC 13D | 2022-11-14 | Kinnevik AB (publ) | Babylon Holdings Ltd | 115,433,522 | 18.6% | EDGAR |
| SC 13G/A | 2022-05-25 | Kinnevik AB (publ) | Babylon Holdings Ltd | 54,942,568 | 16.6% | EDGAR |
| SC 13G | 2022-02-08 | Invik S.A. | Kinnevik AB (publ) | 54,942,568 | 16.6% | EDGAR |
| SC 13D/A | 2021-04-15 | Kinnevik AB (publ) | Teladoc Health, Inc. | 7,491,124 | 4.9% | EDGAR |
| SC 13D/A | 2020-12-21 | Kinnevik AB (publ) | Teladoc Health, Inc. | 7,491,124 | 5.2% | EDGAR |
| SC 13D | 2020-11-09 | Kinnevik AB (publ) | Teladoc Health, Inc. | 7,491,124 | 5.2% | EDGAR |
| SC 13D/A | 2020-11-03 | Kinnevik AB (publ) | Livongo Health, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-01-21 | Kinnevik AB (publ) | MILLICOM INTERNATIONAL CELLULAR SA | 0 | 0.0% | EDGAR |
| SC 13D | 2019-07-31 | Kinnevik AB (publ) | Livongo Health, Inc. | 12,653,927 | 13.9% | EDGAR |
| SC 13G | 2019-02-01 | Kinnevik AB (publ) | MILLICOM INTERNATIONAL CELLULAR SA | 37,835,438 | 37.2% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.